Kidney Transplantation Clinical Trial
Official title:
Multicenter International Observational Study to Build and Validate Multidimensional Risk Score in the Clinical Setting of Kidney Allograft Biopsies to Predict Long-term Allograft Survival
To further develop personalized medicine in kidney transplantation and improve transplant
patient outcomes, attention has been given to define early surrogate endpoints that might aid
therapeutic interventions, clinical trials and clinical decision-making.
Despite a clear pressing need, no population-scale prognostication system exists that will
combine traditional factors and biomarker candidates to represent the complete spectrum of
risk predicting parameters. To adequately predict transplant patients' individual risks of
allograft loss, this would require a complex integration of data, including: donor data,
recipient characteristics, transplant characteristics, allograft precision phenotypes,
ethnicity, immunosuppressive regimen monitoring, allograft infections, acute kidney injuries,
and recipient immune profiles.
This project aims:
1. To develop a generalizable, transportable, mechanistically and data driven composite
surrogate end point in kidney transplantation;
2. To validate several risk scores to predict kidney allograft survival and response to
treatment of individual patients;
Eventually, it will provide an easily accessible tool to calculate individual patients' risk
profiles after kidney transplantation, by using datasets from prospective cohorts and post
hoc analysis of randomized control trial datasets.
Background The field of kidney transplantation currently lacks robust models to predict
long-term allograft failure, which represents a major unmet need in clinical care and
clinical trials. This study aims to generate and validate an accessible scoring system that
predicts individual patients' risk of long-term kidney allograft failure.
Main Outcome(s) and Measure(s)
A score based on classical statistical approaches to model determinants of allograft and
patient survival (Cox model, multinomial regression). These models will be further completed
with statistical approaches derived from artificial intelligence and machine learning.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04910867 -
APOL1 Genetic Testing Program for Living Donors
|
N/A | |
Completed |
NCT02723591 -
To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients
|
Phase 4 | |
Completed |
NCT05945511 -
Silent Gallbladder Stone in Kidney Transplantation Recipients: Should it be Treated?
|
||
Completed |
NCT02234349 -
Bile Acids and Incretins in Pancreas Kidney Transplant Patients
|
N/A | |
Completed |
NCT04496401 -
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
|
Phase 4 | |
Recruiting |
NCT05917795 -
Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Kidney Transplant Candidates
|
N/A | |
Not yet recruiting |
NCT05934383 -
Safety and Efficacy of Ultrasound Renal Denervation in Kidney Transplantation Patients With Uncontrolled Hypertension
|
N/A | |
Withdrawn |
NCT04936971 -
Introduction of mTor Inhibitors and the Activation of the Cytomegalovirus (CMV) -Specific Cellular Immune Response
|
Phase 4 | |
Not yet recruiting |
NCT04540640 -
Oxygenated Machine Preservation in Kidney Transplantation
|
N/A | |
Not yet recruiting |
NCT03090828 -
Economic Evaluation of an Education Platform for Patients With End-stage Renal Disease
|
N/A | |
Recruiting |
NCT02908139 -
Noninvasive Perioperative Monitoring of Arterial Stiffness, Volume and Nutritional Status in Stable Renal Transplant Recipients
|
N/A | |
Completed |
NCT02560558 -
Bela 8 Week Dosing
|
Phase 4 | |
Terminated |
NCT02417870 -
Ultra-low Dose Subcutaneous IL-2 in Renal Transplantation
|
Phase 1/Phase 2 | |
Recruiting |
NCT02154815 -
Pre-emptive Kidney Transplantation Quality of Life
|
N/A | |
Completed |
NCT02235571 -
iChoose Decision Kidney Aid for End-Stage Renal Disease Patients
|
N/A | |
Enrolling by invitation |
NCT01905514 -
ImPRoving Adherence to Immunosuppressive Therapy by Mobile Internet Application in Solid Organ Transplant Patients
|
N/A | |
Completed |
NCT02147210 -
Chronic Transplant Glomerulopathy and Regulation of Expression of Ephrin B1
|
N/A | |
Recruiting |
NCT01699360 -
The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients
|
Phase 4 | |
Completed |
NCT01672957 -
ORANGE Study: An Observational Study on Renal Function in Kidney Transplant Patients on Immunosuppressive Therapy Containing CellCept (Mycophenolate Mofetil)
|
N/A | |
Terminated |
NCT01436305 -
Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation
|
Phase 2 |